Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports

Area of Science:

• Pediatric Psychiatry
• Neuroscience
• Clinical Psychology

Background:

• Obsessive-compulsive disorder (OCD) is a debilitating mental health condition.
• Limited research exists on treating severe pediatric OCD in very young children (4-5 years old).
• Understanding treatment efficacy and safety in this population is crucial.

Observation:

• Three preschool-aged children (4-5 years old) diagnosed with OCD were studied.
• Symptoms included severe ego-dystonic obsessions (sexual, aggressive, religious themes) and contamination obsessions with cleaning compulsions.
• No physical or neurological abnormalities were found in the patients.

Findings:

• Sertraline monotherapy (up to 50 mg/day) led to symptom resolution in one patient.
• Combination therapy with sertraline and risperidone (0.5 mg/day) resolved symptoms in two patients.
• Both treatment regimens demonstrated effectiveness in this young pediatric cohort.

Implications:

• Pharmacological interventions, including sertraline and risperidone, may be effective for early-onset pediatric OCD.
• This study contributes valuable data on the safety and efficacy of psychotropic medications in a rarely studied age group.
• Further research is warranted to establish long-term outcomes and safety profiles for treating very young children with OCD.